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Summary
In order to begin searching for new markers for safe exercise training in patients with cardiac diseases, we tested 
the sensitivity and reliability of the short-term variability of repolarization (STVQT) in comparison with QT interval, QTc, 
and Tpeak-Tend interval (Tp-e) in patients with cardiac diseases. 
Nine patients (8 men, 1 woman; 58 ± 10 years) were enrolled. The cardiac rehabilitation (CR) program consisted of 
walking, bicycling on an ergometer, and calisthenics for 30-50 minutes/session and 3-5 sessions/week for 3 months. 
ECGs of 31 consecutive sinus beats were obtained before and after the CR program. RR and QT intervals were meas-
ured in the aVL lead. The mean orthogonal distance from the diagonal to the points of the Poincaré plots was determined 
using the following equation; STVQT [= Σ |QTn+1-QTn/(30 × 2
1/2)], as a marker of temporal dispersion of repolarization. 
Also, Tp-e of 5 consecutive beats was measured as a marker of spatial dispersion.
No fatal arrhythmias were observed in the CR. No significant difference was observed in the RR or QT interval be-
tween at baseline and at the end of the CR program. Meanwhile, QTc, STVQT and Tp-e decreased significantly from 429 
± 27 to 400 ± 17 (P < 0.01), from 6.8 ± 1.3 to 4.7 ± 1.4 msec (P < 0.001), and from 74.8 (61.2/79.1) to 64.8 (51.4/70.7) 
msec (median (25th/75th percentile), P < 0.01), respectively.
STVQT together with Tp-e and QTc may reflect the time-courses of safe exercise training.   (Int Heart J 2011; 52: 
304-307)
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Cardiac rehabilitation
While the incidence of cardiac arrest has been reported to be low during supervised sessions of cardiac re-habilitation (CR),1) its fatality rate is high once it 
has happened. Recently, CR has been indicated for patients 
with moderate heart failure who would have higher risk of ar-
rhythmic events than those with mild heart failure, increasing 
the need for sensitive and reliable markers for predicting the 
onset of lethal arrhythmias in CR. Electrophysiological testing, 
including ambulatory Holter monitoring, signal-averaged elec-
trocardiography, autonomic dysfunction and heart rate variabil-
ity tests, QT interval prolongation and spatial dispersion analy-
sis, and programmed ventricular stimulation have been used to 
identify patients at high risk for sudden cardiac death,2-5) which 
can be time-consuming, less sensitive, and possess a lack of 
versatility. 
Temporal dispersion of ventricular repolarization; name-
ly, beat-to-beat variability of repolarization calculated as short-
term variability of QT intervals (STVQT), has been developed 
for a canine sudden cardiac death model.6) Recently, the STVQT 
has been applied to clinical research, showing that patients 
with drug-induced and congenital long-QT syndrome have 
greater values of QTc and STVQT compared with asymptomat-
ic patients.7,8) Furthermore, its clinical usefulness was also con-
firmed in patients with nonischemic heart failure.9) In the 
present study, we tested the sensitivity and reliability of STVQT 
in patients with cardiac diseases who were successfully dis-
charged after the 3-month CR program.
Methods
In the present study, 9 patients (8 men, 1 woman; 58 ± 10 
years) were enrolled, and all were successfully discharged after 
the 3-month CR program. Patient profiles are summarized in 
Table I. Indications for CR were postcardiac surgery [coronary 
bypass, (cases 1, 3, 7, and 8); valvular surgery, (case 6)]; recent 
percutaneous coronary intervention (cases 2, 4, and 9); and 
noncoronary heart disease (case 5). Inclusion criteria were at 
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rest electrocardiographic recording in sinus rhythm that al-
lowed analysis of 31 consecutive beats without premature su-
praventricular or ventricular complexes before and after the 
3-month CR program. At baseline, diuretics were prescribed 
for 5 patients (cases 1, 5, 6, 7, and 8), angiotensin-converting 
enzyme inhibitors for 3 (cases 5, 6, and 9), angiotensin II type-
1 receptor blocker for 1 (case 2), nitrates for 3 (cases 1, 2, and 
7), beta-blockers for 6 (cases 1, 3, 5, 6, 7, and 8), and calcium 
antagonists for 3 (cases 1, 3, and 7). None of the patients was 
taking a class I or III antiarrhythmic agent.
CR Program:  The CR program consisted of walking, bicy-
cling on an ergometer and calisthenics with duration of 30-50 
minutes/session and frequency of 3 to 5 sessions/week for 3 
months. Exercise intensity was determined individually at 40-
60% of heart rate reserve (Karvonen’s equation: k = 0.4-0.6), 
an anaerobic threshold level obtained in a maximal symptom-
limited cardiopulmonary exercise test, or at levels 11-13 (“fair-
ly light” to “somewhat hard”) of the 6-20 scale rating of per-
ceived exertion. The exercise program usually began with 
supervised sessions for 1 week, followed by home exercise 
combined with once or twice a week supervised sessions for 
the remaining period of the CR program. Home exercise con-
sisted mainly of brisk walking at a prescribed heart rate for 30-
50 minutes, 3 to 5 times a week. All patients provided written 
informed consent before entering our CR program. 
Electrocardiographic recording:  At the beginning and the end 
of the 3-month CR program, 12-lead electrocardiographic re-
cordings over 3 minutes were performed using the Cardio Star 
FX-7542 ECG recorder (Fukuda Denshi Co., Tokyo) in all 
subjects in a supine position after 10 minutes at rest. Twelve-
lead electrocardiography was calibrated to 50 mm/second and 
20 mm/mV. A single observer manually measured the RR and 
QT intervals of 31 consecutive beats, which were averaged. 
QT intervals were determined in lead aVL from the onset of the 
QRS complex to the end of the T wave employing the method 
of Lepeschkin and Surawicz.10) QT intervals were corrected for 
heart rate (QTc interval) using Bazett’s formula.11)
STV, defined as the mean orthogonal distance from the 
diagonal to the points of the Poincaré plots, was calculated as 
[STVD = Σ|Dn+1-Dn|/(30 × 2
1/2)], where Dn represents the RR or 
QT interval of beat n for each subject. For instance, STVQT [= 
Σ|QTn+1-QTn|/(30 × 2
1/2)], is a recently established sensitive 
marker of temporal dispersion of ventricular repolarization. 
This analysis acknowledges large beat-to-beat differences in 
repolarization duration to a higher degree than previously clini-
cally applied algorithms of QT variability, which are based on 
variance.12)
Tpeak-Tend interval (Tp-e) is a well-known sensitive marker 
of spatial dispersion of ventricular repolarization.13) A single 
observer manually measured Tp-e of 5 consecutive beats, and 
the average was calculated.
Clinical data:  All 9 patients underwent echocardiography 
(Aplio XG ultrasonoscope, Toshiba Co., Tokyo) equipped with 
a 2.5-MHz transducer before starting the CR program. Left 
ventricular (LV) internal diameters were obtained from the 
parasternal short-axis view, approximately at the mid-ventricu-
lar level, using direct two-dimensional measurements or tar-
geted M-mode echocardiography if the M-mode cursor could 
be positioned perpendicular to the septum and LV posterior 
wall. The LV ejection fraction was calculated by the Teichholz 
method.14)
The estimated glomerular filtration rate (eGFR) was cal-
culated, where eGFR = 194 × serum creatine-1.094 × age in 
years-0.287 for men, whereas that for females was obtained by 
adjusting for sex; eGFR female = eGFR × 0.739.15)
Statistical analysis:  Data are presented as the mean ± standard 
Table I.  Patient Profile
Age 
(year)
Gender Underlying heart disease Intervention
LVEF 
(%)
eGFR
 (mL/minute/
1.73m2)
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
Case 9
40
50
70
54
56
68
61
55
67
Male
Male
Male
Male
Male
Female
Male
Male
Male
Ischemic heart disease
Acute myocardial infarction
Effort angina pectoris
Acute myocardial infarction
Idiopathic dilated cardiomyopathy
Aortic valve insufficiency
Acute coronary syndrome
Acute myocardial infarction
Acute myocardial infarction
Coronary artery bypass graft surgery
Percutaneous coronary intervention
Coronary artery bypass graft surgery
Percutaneous coronary intervention
Aortic valve replacement
Coronary artery bypass graft surgery
Coronary artery bypass graft surgery
Percutaneous coronary intervention
35
60
62
62
41
45
37
35
64
67.3
76.4
53.2
75.7
63.9
33.5
45.1
80.6
83.1
LVEF indicates left ventricular ejection fraction and eGFR, estimated glomerular filtration rate.
Figure.  Representative electrocardiogram and associated Poincaré plots 
of the QT and RR intervals. A: Typical tracings of ECG before and after 
the 3-month cardiac rehabilitation (CR) program (in case 4). B: Typical 
examples of Poincaré plots of the QT interval and RR interval. Poincaré 
plots of 31 consecutive QT or RR intervals measured from the same pa-
tient (case 4). Solid and dot arrows indicate Poincaré plots at the baseline 
and the end of the 3-month CR program, respectively.
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deviation or the median (25th/75th percentile) when appropri-
ate. Significant differences of paired data within a parameter 
were determined using the paired t-test or Wilcoxon signed 
rank test. A P value < 0.05 was considered statistically signifi-
cant.
Results
Fatal arrhythmia was not observed in any patient during a 
supervised session of CR. In 4 out of 9 patients (cases 3, 7, 8, 
and 9), cardiopulmonary exercise testing was performed before 
and after the CR program, and their exercise intensity of dura-
bility increased after the CR. Typical tracings of ECG before 
and after the 3-month CR program are depicted in Figure A. 
Changes in the ECG parameters are summarized in Table II. 
Corrected QT intervals (QTc) decreased significantly after the 
end of the 3-month CR program, whereas no significant 
change was detected in the RR or QT intervals. 
Typical examples of Poincaré plots of the QT interval are 
shown in Figure B, in which the QT interval and STVQT de-
creased after the CR program. Changes in the temporal and 
spatial dispersion of ventricular repolarization are also summa-
rized in Table II. STVQT and Tp-e decreased significantly after 
the CR program. 
Discussion
Fatal arrhythmia was not detected during supervised ses-
sions of CR in patients, whereas ameliorations of temporal dis-
persions (ie, STVQT) and spatial dispersion of ventricular repo-
larization (ie, Tp-e) were clearly demonstrated. 
Table II.  Electrocardiographic Parameters at Baseline and the Values at the End of the 3-Month CR 
Program
Subject Time
RR 
(msec)
QT
 (msec)
QTc
STVRR 
(msec)
STVQT 
(msec)
Tp-e
(msec)
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
Case 9
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
Baseline
End
1082
1064
815
796
861
1009
1061
859
864
986
848
861
799
1176
792
814
806
864
881 ± 111
937 ± 129
425 
423 
416 
377 
392 
389 
457 
356 
363 
382 
393 
392 
420 
429 
395 
375 
357 
354 
402 ± 31
386 ± 26
409 
410 
460 
422 
422 
388 
443 
384 
391 
385 
427 
422 
470 
395 
444 
416 
398 
381 
429 ± 27
 400 ± 17*
33.9 
18.6 
10.4 
11.6 
3.3 
5.9 
8.5 
5.4 
6.6 
8.7 
5.9 
5.4 
5.4 
13.2 
9.4 
17.4 
4.2 
6.4 
9.7 ± 9.4
10.3 ± 5.2
6.4 
5.9 
9.0 
5.9 
8.7 
6.6 
5.2 
3.1 
5.9 
3.8 
6.1 
4.5 
6.1 
5.7 
7.1 
4.0 
6.8 
2.6 
6.8 ± 1.3
 4.7 ± 1.4**
77.2
71.6
74.8
71.6
72.8
66.4
129.6
47.2
56.8
52.8
62.4
56.0 
81.2
64.8
78.4
70.4
57.6
45.6
74.8 (61.2/79.1)
 64.8 (51.4/70.7)*
CR indicates cardiac rehabilitation; STVRR, short-term variability of RR intervals; STVQT, short-term 
variability of QT intervals; and Tp-e, Tpeak-Tend intervals. Mean ± standard deviation or median 
(25th/75th percentile). *P < 0.01, **P < 0.001 compared with baseline.
STVQT has been shown to be a clinically useful marker 
for predicting the onset of lethal arrhythmia in patients with 
congenital as well as acquired heart diseases.8,9) In our study, 
STVQT at baseline was 6.8 ± 1.3 msec, which was greater than 
those reported in asymptomatic patients (5.4 ± 2.2 msec)8), but 
was smaller than those in patients with congenital long-QT 
syndrome (9.2 ± 3.9 msec)8) and with nonischemic heart fail-
ure having a history of ventricular tachycardia (10.1 ± 2 
msec).9) Thus, the extent of risk for lethal arrhythmia in the 
currently enrolled patients can be estimated to be moderate 
based on the average values of STVQT. On the other hand, 
comparative analysis suggests that cases 2 and 3 might have 
been at risk for lethal arrhythmias since the STVQT was 9.0 and 
8.7 msec at baseline, respectively. Our previous animal study 
has demonstrated that the presence of severe bradycardia and/
or sustained volume overload to the heart can increase STVQT 
in the canine sudden cardiac death model.16) Since we do not 
know now why the 2 patients showed higher values of STVQT, 
further follow-up studies will be needed for these patients to 
clarify their causal link.
Previous animal studies have shown that a marked in-
crease in STVQT accompanied by QT-interval prolongation can 
be a sign toward the generation of early afterdepolarization.16,17) 
In this study, STVQT as well as Tp-e decreased significantly to-
gether with shortening of QTc after the 3-month CR program, 
indicating a reduction of temporal and spatial dispersions of 
repolarization of the ventricles. Recently, we have demonstrat-
ed that the L/N-type Ca2+ channel blocker cilnidipine de-
creased the STVQT and shortened the QT interval by reducing 
the plasma angiotensin II and aldosterone levels in a canine 
sudden cardiac death model.18) Such amelioration of STVQT 
was not attained after any other pharmacological interven-
tion,18) indicating that the 3-month CR program may have sim-
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ilar effects on patients with cardiac diseases to those attained 
by cilnidipine in the canine sudden cardiac death model. 
Study limitations:   Since the number of patients included in 
the study was small and there is no control group, the current 
study can be considered as a pilot study to begin exploring new 
markers for a safe exercise training program in patients with 
cardiac diseases. Our findings need to be confirmed in a larger 
cohort of patients. 
Conclusion:  STVQT together with Tp-e and QTc may reflect the 
time-courses of safe exercise training.
References
 1. Franklin BA, Bonzheim K, Gordon S, Timmis GC. Safety of 
medically supervised outpatient cardiac rehabilitation exercise 
therapy: a 16-year follow-up. Chest 1998; 114: 902-6.
 2. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on 
Sudden Cardiac Death of the European Society of Cardiology. Eur 
Heart J 2001; 22: 1374-450.
 3. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 
guidelines for management of patients with ventricular arrhythmi-
as and the prevention of sudden cardiac death--executive summa-
ry: A report of the American College of Cardiology/American 
Heart Association Task Force and the European Society of Cardi-
ology Committee for Practice Guidelines (Writing Committee to 
Develop Guidelines for Management of Patients with Ventricular 
Arrhythmias and the Prevention of Sudden Cardiac Death) Devel-
oped in collaboration with the European Heart Rhythm Associa-
tion and the Heart Rhythm Society. Eur Heart J 2006; 27: 2099-
140.
 4. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart 
Association/American College of Cardiology Foundation/Heart 
Rhythm Society scientific statement on noninvasive risk stratifica-
tion techniques for identifying patients at risk for sudden cardiac 
death: a scientific statement from the American Heart Association 
Council on Clinical Cardiology Committee on Electrocardiogra-
phy and Arrhythmias and Council on Epidemiology and Preven-
tion. Circulation 2008; 118: 1497-518.
 5. Guidelines for risks and prevention of sudden cardiac death (JCS 
2005). Circ J 2005; 69: (Suppl IV) 1209-52.
 6. Thomsen MB, Truin M, van Opstal JM, et al. Sudden cardiac 
death in dogs with remodeled hearts is associated with larger beat-
to-beat variability of repolarization. Basic Res Cardiol 2005; 100: 
279-87.
 7. Hinterseer M, Thomsen MB, Beckmann BM, et al. Beat-to-beat 
variability of QT intervals is increased in patients with drug-in-
duced long-QT syndrome: a case control pilot study. Eur Heart J 
2008; 29: 185-90.
 8. Hinterseer M, Beckmann BM, Thomsen MB, et al. Relation of in-
creased short-term variability of QT interval to congenital long-
QT syndrome. Am J Cardiol 2009; 103: 1244-8.
 9. Hinterseer M, Beckmann BM, Thomsen MB, et al. Usefulness of 
short-term variability of QT intervals as a predictor for electrical 
remodeling and proarrhythmia in patients with nonischemic heart 
failure. Am J Cardiol 2010; 106: 216-20.
 10. Lepeschkin E, Surawicz B. The measurement of the Q-T interval 
of the electrocardiogram. Circulation 1952; 6: 378-88.
 11. Bazett HC. An analysis of the time-relations of electrocardio-
grams. Heart 1920; 7: 353-70.
 12. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, To-
maselli GF. Beat-to-beat QT interval variability: novel evidence 
for repolarization lability in ischemic and nonischemic dilated car-
diomyopathy. Circulation 1997; 96: 1557-65.
 13. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, et al. Tpeak-
Tend and Tpeak-Tend dispersion as risk factors for ventricular tachy-
cardia/ventricular fibrillation in patients with the Brugada syn-
drome. J Am Coll Cardiol 2006; 47: 1828-34. 
 14. Teichholz LE, Cohen MV, Sonnenblick EH, Gorlin R. Study of 
left ventricular geometry and function by B-scan ultrasonography 
in patients with and without asynergy. N Engl J Med 1974; 291: 
1220-6. 
 15. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated 
GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 
982-92. 
 16. Takahara A, Sugiyama A, Ishida Y, et al. Long-term bradycardia 
caused by atrioventricular block can remodel the canine heart to 
detect the histamine H1 blocker terfenadine-induced torsades de 
pointes arrhythmias. Br J Pharmacol 2006; 147: 634-41.
 17. Takahara A, Nakamura Y, Sugiyama A. Beat-to-beat variability of 
repolarization differentiates the extent of torsadogenic potential of 
multi ion channel-blockers bepridil and amiodarone. Eur J Phar-
macol 2008; 596: 127-31.
 18. Takahara A, Nakamura Y, Wagatsuma H, et al. Long-term block-
ade of L/N-type Ca2+ channels by cilnidipine ameliorates repolari-
zation abnormality of the canine hypertrophied heart. Br J Phar-
macol 2009; 158: 1366-74.
